This study investigates differences in the effects of comorbidities on survival in Medicare beneficiaries with prostate cancer. Medicare data were used to assemble a cohort of 65- to 76-year-old Black (n = 6,402) and White (n = 47,458) men with incident localized prostate cancer in 1999 who survived ≥1 year postdiagnosis. Comorbidities were more prevalent among Blacks than among Whites. For both races, greater comorbidity was associated with decreasing survival rates; however, the effect among Blacks was smaller than in Whites. After adjusting for age, socioeconomic status, and community characteristics, the association between increasing comorbidities and survival remained weaker for Blacks than for Whites, and racial disparity in survival decreased with increasing number of comorbidities. Differential effects of comorbidities on survival were also evident when examining different classes of comorbid conditions. Adjusting for treatment had little impact on these results, despite variation in the racial difference in receipt of prostatectomy with differing comorbidity levels.
Alibhai, S.M., Leach, M., Tomlinson, G., Krahn, M.D., Fleshner, N., Holowaty, E., et al. (2005). 30-Day mortality and major complications after radical prostatectomy: Influence of age and comorbidity. Journal of the National Cancer Institute, 97, 1525-1532.
2.
Armstrong, K., Ravenell, K.L., McMurphy, S., & Putt, M. (2007). Racial/ethnic differences in physician distrust in the United States. American Journal of Public Health, 97, 1283-1289.
3.
Asch, D.A., & Armstrong, K. (2007). Aggregating and partitioning populations in health care disparities research: Differences in perspective. Journal of Clinical Oncology, 25, 2117-2121.
4.
Begg, C.B., Riedel, E.R., Bach, P.B., Kattan, M.W., Schrag, D., Warren, J.L., et al. (2002). Variations in morbidity after radical prostatectomy . New England Journal of Medicine, 346, 1138-1144.
5.
Chirinos, J.A., Veerani, A., Zambrano, J.P., Schob, A., Perez, G., Mendez, A.J., et al. (2007). Evaluation of comorbidity scores to predict all-cause mortality in patients with established coronary artery disease. International Journal of Cardiology, 117, 97-102.
6.
Concato, J., Horwitz, R.I., Feinstein, A.R., Elmore, J.G., & Schiff, S.F. (1992). Problems of comorbidity in mortality after prostatectomy . JAMA: The Journal of the American Medical Association, 267, 1077-1082.
7.
Dunlop, D.D., Song, J., Manheim, L.M., Daviglus, M.L., & Chang, R.W. (2007). Racial/ethnic differences in the development of disability among older adults. American Journal of Public Health, 97, 2209-2215.
8.
Elixhauser, A., Steiner, C., Harris, D.R., & Coffey, R.M. (1998). Comorbidity measures for use with administrative data. Medical Care, 36, 8-27.
9.
Feinglass, J., Lin, S., Thompson, J., Sudano, J., Dunlop, D., Song, J., et al. (2007). Baseline health, socioeconomic status, and 10-year mortality among older middle-aged Americans: Findings from the Health and Retirement Study, 1992 2002. Journal of Gerontology . Series B, Psychological Sciences and Social Sciences, 62, S209-S217.
10.
Ferrier, M.B., Spuesens, E.B., Le Cessie, S., & Baatenburg de Jong, R.J. (2005). Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Archives of Otolaryngology- Head and Neck Surgery, 131, 27-32.
11.
Fisher, E.S., Whaley, F.S., Krushat, W.M., Malenka, D.J., Fleming, C., Baron, J.A., et al. (1992). The accuracy of Medicare's hospital claims data: Progress has been made, but problems remain. American Journal of Public Health, 82, 243-248.
12.
Fouad, M.N., Mayo, C.P., Funkhouser, E.M., Irene Hall, H., Urban, D.A., & Kiefe, C.I. (2004). Comorbidity independently predicted death in older prostate cancer patients, more of whom died with than from their disease. Journal of Clinical Epidemiology, 57, 721-729.
13.
Freeman, V.L., Durazo-Arvizu, R., Keys, L.C., Johnson, M.P., Schafernak, K., & Patel, V.K. (2004). Racial differences in survival among men with prostate cancer and comorbidity at time of diagnosis. American Journal of Public Health, 94, 803-808.
14.
Godley, P.A., Schenck, A.P., Amamoo, M.A., Schoenbach, V.J., Peacock, S., Manning, M., et al. (2003). Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. Journal of the National Cancer Institute, 95, 1702-1710.
15.
Gomez, S.L., O'Malley, C.D., Stroup, A., Shema, S.J., & Satariano, W.A. (2007). Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: Impact of neighborhood socioeconomic status, treatment and comorbidity. BMC Cancer, 7, 193.
16.
Gross, C.P., Smith, B.D., Wolf, E., & Andersen, M. (2008). Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002? Cancer, 112, 900-908.
17.
Hochberg, Y. (1988). A sharper Bonferroni procedure for multiple tests of significance. Biometrika, 75, 800-803.
18.
Institute of Medicine of the National Academies. (2002). Unequal treatment: Confronting racial and ethnic disparities in health care. Retrieved March 13, 2009, from http://www.iom.edu/?id=16740
19.
Johnson, N.E. (2000). The racial crossover in comorbidity, disability, and mortality. Demography, 37, 267-283.
20.
Kelley-Moore, J.A., & Ferraro, K.F. (2004). The Black/White disability gap: Persistent inequality in later life? Journal of Gerontology. Series B, Psychological Sciences and Social Sciences , 59, S34-S43.
21.
Kestenbaum, B. (1992). A description of the extreme aged population based on improved Medicare enrollment data. Demography, 29, 565-580.
22.
Kung, H.-C., Hoyert, D.L., Xu, J., & Murphy, S.L. (2008, April 24). Table 3. Number of deaths and death rates by age, race, and sex: United States, 2005. National Vital Statistics Reports, 56(10). Retrieved January 17, 2008, from http://www.cdc.gov/nchs/data/nvsr/nvsr56/nvsr56_10.pdf
23.
Lesens, O., Methlin, C., Hansmann, Y., Remy, V., Martinot, M., Bergin, C., et al. (2003). Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: A prospective study using the Charlson weighted index of comorbidity. Infection Control and Hospital Epidemiology, 24, 890-896.
24.
Librero, J., Peiro, S., & Ordinana, R. (1999). Chronic comorbidity and outcomes of hospital care: Length of stay, mortality, and readmission at 30 and 365 days. Journal of Clinical Epidemiology, 52, 171-179.
25.
Manton, K.G., Poss, S.S., & Wing, S. (1979). The Black/White mortality crossover: Investigation from the perspective of the components of aging. Gerontologist , 19, 291-300.
26.
Martins, M., & Blais, R. (2006). Evaluation of comorbidity indices for inpatient mortality prediction models. Journal of Clinical Epidemiology , 59, 665-669.
27.
Massey, D., & Denton, N. (1988). The dimensions of residential segregation. Social Forces, 67, 281-315.
28.
Mayberry, R.M., Coates, R.J., Hill, H.A., Click, L.A., Chen, V.W., Austin, D.F., et al. (1995). Determinants of Black/White differences in colon cancer survival. Journal of the National Cancer Institute , 87, 1686-1693.
29.
McGee, D., Cooper, R., Liao, Y., & Durazo-Arvizu, R. (1996). Patterns of comorbidity and mortality risk in Blacks and Whites. Annals of Epidemiology , 6, 381-385.
30.
Miles, T.P., & Bernard, M.A. (1992). Morbidity, disability, and health status of Black American elderly: A new look at the oldest-old. Journal of the American Geriatrics Society, 40, 1047-1054.
31.
Monami, M., Lambertucci, L., Lamanna, C., Lotti, E., Marsili, A., Masotti, G., et al. (2007). Are comorbidity indices useful in predicting all-cause mortality in Type 2 diabetic patients? Comparison between Charlson index and disease count. Aging Clinical and Experimental Research , 19, 492-496.
32.
The National Comprehensive Cancer Network (NCCN). (2004). NCCN Clinical Practice Guidelines in Oncology: Prostate cancer. Retrieved March 13, 2009, from http://www.nccn.org/professionals/physician_gls/PDF/prostate.pdf
33.
Ouellette, J.R., Small, D.G., & Termuhlen, P.M. (2004). Evaluation of Charlson-age comorbidity index as predictor of morbidity and mortality in patients with colorectal carcinoma. Journal of Gastrointestinal Surgery , 8, 1061-1067.
34.
Polednak, A.P., & Flannery, J.T. (1992). Black versus White racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut. Cancer, 70, 2152-2158.
35.
Sachdev, M., Sun, J.L., Tsiatis, A.A., Nelson, C.L., Mark, D.B., & Jollis, J.G. (2004). The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. Journal of the American College of Cardiology, 43, 576-582.
36.
Schapira, M.M., McAuliffe, T.L., & Nattinger, A.B. (1995). Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. Medical Care, 33, 1079-1088.
37.
Sudano, J.J., & Baker, D.W. (2006). Explaining US racial/ethnic disparities in health declines and mortality in late middle age: The roles of socioeconomic status, health behaviors, and health insurance. Social Science & Medicine, 62, 909-922.
38.
Sundararajan, V., Henderson, T., Perry, C., Muggivan, A., Quan, H., & Ghali, W.A. (2004). New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. Journal of Clinical Epidemiology, 57, 1288-1294.
39.
Tammemagi, C.M., Nerenz, D., Neslund-Dudas, C., Feldkamp, C., & Nathanson, D. (2005). Comorbidity and survival disparities among Black and White patients with breast cancer. JAMA: The Journal of the American Medical Association, 294, 1765-1772.
40.
Tammemagi, C.M., Neslund-Dudas, C., Simoff, M., & Kvale, P. (2004). In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. Journal of Clinical Epidemiology, 57, 597-609.
41.
West, D.W., Satariano, W.A., Ragland, D.R., & Hiatt, R.A. (1996). Comorbidity and breast cancer survival: A comparison between Black and White women. Annals of Epidemiology, 6, 413-419.
42.
Wilt, T.J., Macdonald, R., Rutks, I., Shamliyan, T.A., Taylor, B.C., & Kane, R.L. (2008). Systematic review: The comparative effectiveness and harms of treatments for clinically localized prostate cancer. Annals of Internal Medicine, 148, 435-448.
43.
Yancik, R., Wesley, M.N., Ries, L.A., Havlik, R.J., Long, S., Edwards, B.K., et al. (1998). Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: A population-based study. Cancer, 82, 2123-2134.
